SIREN : 521494419
ECG DEVELOPPEMENT is a French company founded 16 years ago, specialized in the sector Activités des sociétés holding. Based in GAP (05000), this company of category PME shows in 2018 a revenue of 604 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | 604 218 € | 519 823 € | 400 371 € |
| Net income | 562 231 € | 242 344 € | 378 093 € | 189 623 € | 749 486 € | 56 161 € | 73 106 € |
| EBITDA | N/C | N/C | N/C | N/C | 54 134 € | 94 627 € | 42 540 € |
| Net margin | N/C | N/C | N/C | N/C | 124.0% | 10.8% | 18.3% |
In 2023, ECG DEVELOPPEMENT generates positive net income of 562 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 73 k€ -> 562 k€.
562 231 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 98%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.47%
97.631%
72.6%
In 2023, the debt ratio of ECG DEVELOPPEMENT (0.47) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2023, the financial autonomy of ECG DEVELOPPEMENT (97.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 1108.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1108.81
In 2023, the liquidity ratio of ECG DEVELOPPEMENT (1108.81) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 63 transactions of similar company sales
in 2023,
the value of ECG DEVELOPPEMENT is estimated at
5 244 391 €
(range 956 019€ - 7 782 222€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ECG DEVELOPPEMENT with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of ECG DEVELOPPEMENT in 2018 is 604 k€.
Yes, ECG DEVELOPPEMENT generated a net profit of 562 k€ in 2023.
The headquarters of ECG DEVELOPPEMENT is located in GAP (05000), in the department Hautes-Alpes.
The tax return of ECG DEVELOPPEMENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ECG DEVELOPPEMENT operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.